Molecular Mechanisms of Dementia—Application to Its Biomarkers
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 7609
Special Issue Editors
Interests: plasma biomarkers; neuron-derived extracellular vesicles; liquid biopsy
Special Issue Information
Dear Colleagues,
Recently, the molecular mechanisms of dementia are gradually becoming clearer. Among them, for Alzheimer's disease (AD), the "amyloid cascade hypothesis" has been proposed and has been supported by many researchers. Based on this hypothesis, diagnostic biomarkers for AD have been established. The main ones are amyloid PET and the measurement of Aβ40, Aβ42, and phosphorylated tau in cerebrospinal fluid (CSF). However, amyloid PET is expensive, and CSF collection has invasive problems, leaving doubts about its clinical applicability. The amyloid hypothesis is also leading AD-modifying agents such as amyloid vaccine therapy to clinical use. Because it has been pointed out that such interventions cannot be expected to be effective unless they are performed very early in the disease, early diagnosis is becoming more important. Against this background, the establishment of blood biomarkers for AD that can be easily measured is an urgent issue.
On the other hand, clinical trials of these AD-modifying agents have been struggling, and questions have been raised as to whether the amyloid hypothesis is correct. Therefore, a paradigm shift may be necessary for the hypothesis of the molecular mechanisms of dementia.
In this Special Issue, we would like to introduce the molecular mechanisms of dementia, including the "amyloid cascade hypothesis," and introduce their application to biomarkers of dementia.
Prof. Takashi Kudo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- plasma
- serum
- phosphorylated tau
- neurofilament L
- Aβ40
- Aβ42
- extracellular vesicles
- exosome